【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 15
1.2 List of Figures 17
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 18
3 Disease Overview 19
3.1 Etiology and Pathophysiology 19
3.1.1 Etiology 19
3.1.2 Pathophysiology 20
3.2 Symptoms 22
3.3 Diagnosis 22
3.4 Prognosis 23
3.5 Quality of Life 23
4 Epidemiology 25
4.1 Disease Background 25
4.1.1 GHD in Children 25
4.1.2 GHD in Adults 26
4.2 Risk Factors and Comorbidities 26
4.3 Global Trends 28
4.3.1 GHD in Children 29
4.3.2 GHD in Adults 31
4.4 Forecast Methodology 32
4.4.1 Sources Used 36
4.4.1.1 7MM 36
4.4.1.2 Diagnosed Cases of GHD in Children 37
4.4.1.3 Diagnosed Cases of GHD in Adults 38
4.4.1.4 GHD Etiological Classification in Children 38
4.4.1.5 GHD Etiological Classification in Adults 39
4.4.2 Sources Not Used 40
4.4.3 Forecast Assumptions and Methods 41
4.4.3.1 Temporal Trends 41
4.4.3.2 Sex-Specific Trends 41
4.4.3.3 Diagnosed Prevalent Cases of GHD in Children 41
4.4.3.4 Diagnosed Prevalent Cases of GHD in Adults 42
4.4.3.5 GHD Etiological Classification in Children 43
4.4.3.6 GHD Etiological Classification in Adults 43
4.5 Epidemiological Forecast of GHD (2014-2024) 44
4.5.1 Diagnosed Prevalent Cases of GHD 44
4.5.2 Diagnosed Prevalent Cases of GHD by Sex 46
4.5.3 Diagnosed Prevalent Cases of GHD by Age 47
4.5.3.1 Diagnosed Prevalent Cases of GHD in Children 47
4.5.3.2 Diagnosed Prevalent Cases of GHD in Adults 49
4.5.4 Age-Adjusted Diagnosed Prevalence of GHD 50
4.5.5 Diagnosed Prevalent Cases of GHD in Children by Etiological Classification 51
4.5.6 Diagnosed Prevalent Cases of GHD in Adults by Etiological Classification 52
4.6 Discussion 53
4.6.1 Epidemiological Forecast Insight 53
4.6.2 Limitations of the Analysis 54
4.6.3 Strengths of the Analysis 55
5 Competitive Assessment 56
5.1 Overview 56
5.2 Treatment Algorithm 56
5.3 Market Access, Reimbursement, and Clinical Practice 58
5.4 Product Profiles — Recombinant Human Growth Hormones 60
5.4.1 Overview 60
5.4.1.1 Genotropin 61
5.4.1.2 Humatrope 62
5.4.1.3 Norditropin 62
5.4.1.4 Nutropin AQ 63
5.4.1.5 Saizen 64
5.4.1.6 Tev-Tropin/Zomacton/Growject 64
5.4.1.7 Omnitrope Biosimilar 65
5.4.2 Efficacy 68
5.4.2.1 Pediatric GHD 68
5.4.2.2 Adult GHD 68
5.4.3 Safety 69
5.4.3.1 Pediatric GHD 69
5.4.3.2 Adult GHD 69
5.4.4 SWOT Analysis 70
6 Unmet Needs Assessment and Opportunity Analysis 71
6.1 Overview 71
6.2 Improved Adherence and Compliance 72
6.2.1 Unmet Needs 72
6.2.2 Gap Analysis 74
6.2.3 Opportunity 74
6.3 Early Diagnosis 75
6.3.1 Unmet Needs 75
6.3.2 Gap Analysis 75
6.3.3 Opportunity 76
6.4 Disease Awareness and Regulatory Policy in Japan 76
6.4.1 Unmet Needs 76
6.4.2 Gap Analysis 77
6.4.3 Opportunity 77
6.5 Insurance Policies that Impact Patient Access 78
6.5.1 Unmet Needs 78
6.5.2 Gap Analysis 79
6.5.3 Opportunity Analysis 79
6.6 Safer Treatments for Cancer Survivors 79
6.6.1 Unmet needs 79
6.6.2 Gap Analysis 80
6.6.3 Opportunity Analysis 80
7 R&D Strategies 81
7.1 Overview 81
7.1.1 Development of Long-Acting Biobetter Growth Hormones 81
7.1.2 Novel Drug Delivery Strategies 82
7.1.3 Targeting the Growth Hormone Releasing Hormone 83
7.1.4 Licensing and Acquisitions 83
7.2 Clinical Trial Design 84
7.2.1 Current Clinical Trial Design 84
7.2.2 Future Clinical Trial Design 85
8 Pipeline Assessment 88
8.1 Overview 88
8.2 Promising Drugs in Clinical Development 89
8.2.1 Somatropin Biopartners 91
8.2.1.1 Overview 91
8.2.1.2 Efficacy 92
8.2.1.3 Safety 92
8.2.1.4 SWOT Analysis 93
8.2.2 NNC0195-0092 93
8.2.2.1 Overview 93
8.2.2.2 Efficacy 95
8.2.2.3 Safety 95
8.2.2.4 SWOT Analysis 95
8.2.3 MOD-4023 96
8.2.3.1 Overview 96
8.2.3.2 Efficacy 97
8.2.3.3 Safety 97
8.2.3.4 SWOT Analysis 98
8.2.4 VRS-317 98
8.2.4.1 Overview 98
8.2.4.2 Efficacy 99
8.2.4.3 Safety 99
8.2.4.4 SWOT Analysis 100
8.2.5 ACP-001 100
8.2.5.1 Overview 100
8.2.5.2 Efficacy 101
8.2.5.3 Safety 101
8.2.5.4 SWOT Analysis 102
8.2.6 TV-1106 102
8.2.6.1 Overview 102
8.2.6.2 Efficacy 103
8.2.6.3 Safety 103
8.2.6.4 SWOT Analysis 104
8.3 Innovative Early-Stage Approaches 104
9 Pipeline Valuation Analysis 107
9.1 Clinical Benchmark of Key Pipeline Drugs 107
9.2 Commercial Benchmark of Key Pipeline Drugs 109
9.3 Competitive Assessment 112
9.4 Top Line Ten Year Forecast 113
9.4.1 US 118
9.4.2 5EU 119
9.4.3 Japan 120
10 Appendix 122
10.1 Bibliography 122
10.2 Abbreviations 130
10.3 Methodology 133
10.4 Forecasting Methodology 133
10.4.1 Diagnosed GHD patients 133
10.4.2 Percent Drug-Treated Patients 133
10.4.3 Drugs Included in Each Therapeutic Class 134
10.4.4 Launch and Patent Expiry Dates 134
10.4.5 General Pricing Assumptions 135
10.4.6 Individual Drug Assumptions 136
10.4.7 Pricing of Pipeline agents 139
10.5 Physicians Included in This Study 141
10.6 Payers Included in This Study 142
10.7 Primary Research – Prescriber Survey 143
10.8 About the Authors 144
10.8.1 Analyst 144
10.8.2 Epidemiologist 144
10.8.3 Therapy Director – CVMD 145
10.8.4 Global Head of Healthcare 145
10.9 About GlobalData 146
10.10 Disclaimer 146
【レポート販売概要】
■ タイトル：成長ホルモン分泌不全症治療薬の世界市場機会分析■ 英文：OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecast to 2024
■ 発行日：2015年8月1日
■ 調査会社：GlobalData
■ 商品コード：GDHC029POA
■ 調査対象地域：グローバル
- 世界の食品診断システムおよび消耗品市場動向（～2018）The food diagnostics market size is projected to increase with rising concerns over food quality and safety, and the implementation of stringent regulations on food safety and foodborne illness prevention. Globalization of food trade has further extended the scope for the food diagnostics market. The emerging markets with increasing demand for food testing are estimated to generate potential oppor …
- 硝酸ナトリウムの世界市場2016-2020About Sodium Nitrate Sodium nitrate is a crystalline salt used to make fertilizers and gunpowder. It is found in the Earth’s crust in mineral deposits called caliche ore. Chile and Peru are the global leaders in the production of sodium nitrate; that is why it is also known as Chile or Peru saltpeter. Sodium nitrate is a strong oxidizer. It is an essential plant nutrient and helps improve the nutr …
- トラベルワクチン（海外渡航者ワクチン）の世界市場About Travel Vaccines Vaccines are biological preparations that provide immunity to a particular disease by stimulating the immune system. The vaccines can be administered orally, intra-nasally, or through injections in both adults and children. Government bodies such as the CDC and the NHS have mandated the vaccination of emigrants traveling to disease-prone areas to prevent the spread of infecti …
- 自動車用打ち抜き装置の世界市場2018-2022About Automotive Die-stamping Equipment Die-Stamping equipment is a tool that helps in forming the desired shape by means of deformation without the removal of any material. The die-stamping equipment consists of two dies, between which the material required is pressed with appropriate stress to form the desired shape. Technavio’s analysts forecast the global automotive die-stamping equipment mark …
- 世界の医療用電力供給市場The global market for medical power supply was estimated at $642.0 million in 2012 and is poised to grow at a CAGR of 6.2% from 2012 to 2017 to reach $866.8 million by 2017. The global market is categorized into three broad segments - by technology, by type, and by application. The global market by technology is broadly categorized into AC-DC and DC-DC power supply. The market by type is categoriz …
- 世界の中小企業IT支出市場（2014-2018）About SMBs Small and medium-sized (SMB) businesses are defined based on the number of employees and annual revenue generated. Micro businesses are those that have less than 10 employees, small businesses are those that employ less than 100 employees, and mid-sized businesses are those that have more than 100 but less than 1,000 employees. The IT requirement of an SMB differs based on business size …
- グローバル製薬産業サーベイ（2013-2014）：市場動向、購買戦略Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global pharmaceutical industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global pharmaceutical industry. The report includes key topics such as global pharmaceutical industry buyer expenditure and procuremen …
- 世界の保険ビジネス・プロセス・アウトソーシング(BPO)市場About Insurance BPO Insurance BPO is a sub-segment of the Banking, Financial Services, and Insurance (BFSI) BPO segment. BPO service providers support some of the leading financial institutions and custodians in the world. The value chain of the Insurance industry comprises of product development, marketing, administration, asset management, and claims management. Insurance BPO is a segment of out …
- モバイルゲームの著作権侵害（Mobile Gaming Piracy: Market Analysis, Initiatives and Solutions to Defeat Game Piracy in 3G, LTE and the Cloud Ecosystem）With mobile gaming taking on an increasingly more prominent role among gamers, and representing an increasingly important source of revenue for game developers, the issue of mobile gaming privacy has become a very hot topic. Pirated games are by definition those games that have stolen intellectual property in the form of a look-alike game, core design, engineering, or even actual software. Billion …
- 日本の感染症検査市場2014This report provides an overview of the Japanese infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Table of ContentsBusiness EnvironmentMarket Structure Market Size, Growth, and Major Suppliers' Market SharesList of Tables …
- アルミニウムの世界市場動向2014/2015The report presents a thorough study of aluminum, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing aluminum worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: aluminum production in the country, major manufac …
- 心臓再同期療法除細動器（CRT-D） の世界市場2016-2020About the Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market Heart failure, a condition when the heart cannot pump enough blood to meet the body’s need, is one of the leading causes of death. Heart failure and stroke, if occurred together, can lead to major health problems or cause sudden death. Irregularity in ventricular rate can lead to reduction of diastolic dysfunction, a conditio …
- スチレン系ブロック共重合体（SBC）及び誘導体の世界市場2016-2020：SBS、SIS、SEBS、HSBCStyrenic block copolymers, commonly known as SBCs, belong to the family of thermoplastic elastomers. These polymers are consumed in bulk compared with other thermoplastic elastomers and exhibit properties similar to rubber, though they are processed as thermoplastics. They are added in additives and other high-performance polymeric compounds for the formulation of many products. Technavio’s analys …
- 高耐熱複合材料の世界市場：PMC（高分子マトリックス複合材料）、CMC（セラミック基複合材料）、MMC（金属基複合材料）The market size of high-temperature composite materials is projected to reach USD 5.01 Billion by 2021, at a CAGR of 8.41% during the forecast period. The introduction of safety norms in public transport as well as increasing demand for lightweight and high-performance composite materials in the aerospace & defense, transportation, and energy & power applications are key factors responsible for th …
- アルファ1-アンチトリプシン薬の世界市場2016-2020About Alpha-1 antitrypsin Drugs Alpha-1 antitrypsin, also known as an alpha-1 protease inhibitor (A1PI), is a glycoprotein produced in the liver that helps in the inactivation of enzymes such as elastase, which break down proteins during inflammation induced by some injury. The decline in alpha-1 antitrypsin levels in the blood results in a rare genetic condition known as alpha-1 antitrypsin defic …
